Scripps Neurologist Weighs in on Parkinson's Psychosis Drug
Physician discusses FDA-approved drug with U-T
Physician discusses FDA-approved drug with U-T
Melissa Houser, MD, founder and clinical director of the Parkinson's Disease and Movement Disorder Center at Scripps Clinic, discussed the benefits and safety risks of an FDA-approved drug used to treat psychosis in Parkinson's disease patients during a recent interview with The San Diego Union-Tribune.
Read the story in The San Diego Union-Tribune: Acadia's Parkinson's drug risk adequately disclosed, says FDA.
Media Contact
- Keith Darce
- 858-678-7121
- darce.keith@scrippshealth.org
- Follow me: @KeithDarce